Published May 6, 2019
| Version v1
Journal article
Open
Determining the fraction of cells with stem-like properties in the HSJD DIPG 007 cell line by limiting dilution assay
- 1. University of Oxford, Structural Genomics Consortium
- 2. University of Oxford, Structural Genomics Consortium, Nuffield Department of Orthopaedics and Musculoskeletal Sciences
Description
A description of how an limiting dilution assay was developed to test the stem-cell-like compartment within the HSJD-DIPG-007 patient derived cell line.
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
Files
(828.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:7f87c0faf507623110b09993f1e426fe
|
828.9 kB | Download |